In Germany began to test a vaccine against the coronavirus in humans. It is reported by The Independent, citing the German Federal Institute for vaccines and biomedical drugs PEI (Institute of Paul Ehrlich) .
Scientific institution issued the first permission for clinical trials from COVID-19. It is reported that the trial of the vaccine produced by the company Biontech, which with regulatory approval to start testing on volunteers. The statement of the Paul Ehrlich Institute said that experts have estimated potential risks and benefits of the drug candidate for testing.
it transpires that the test samples of the vaccine will be given to the group of healthy people as part of a 200 people aged 18 to 55 years. Scientists will test several types of the drug, to assess its impact on the human immune system.
Earlier, the representative of the world health organization (who) in Russia, Melita Vujnović said that the test of the test types vaccine will take at least a year. “Even if everything will go absolutely perfectly, at least 12 to 18 months need to have passed all phases of clinical trials,” he said. According to her, at the moment there are 67 prototypes of the drug against COVID-19, three of them began the first clinical trials.
